Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 December 2018 | Story Leonie Bolleurs | Photo Sonia Small
David Abbey
David Abbey is also serving on the UFS Council’s Finance, Audit, Risk and IT Governance Committee.

David Abbey, a senior banker and transactor in the Acquisition and Leveraged Finance Division at Rand Merchant Bank in Johannesburg, was appointed to the UFS Council.

An undergraduate student of Rhodes University, David is also a proud product of the UFS, having completed his Accounting honours degree at this university. For the past few years, he has also guest lectured on investment banking and financial instruments to Accounting honours students as part of the PwC Financial Instruments Programme.

Large-scale impact

Therefore, his appointment to the Council is particularly special to him.

“Being a member of the Council gives me the platform to have a more large-scale impact on the institution, academic community, the economy, and society. I’m thrilled to be serving alongside an astute body of incredible individuals from whom I will undoubtedly learn,” he says.

Realising his full potential

David is serving on the Council’s Finance, Audit, Risk and IT Governance Committee and his experience in, and knowledge of finance, technology, and audit skills will stand him in good stead. When he’s not developing and structuring innovative, multidisciplinary, and integrated financial solutions for his corporate clients, he loves to be active. He is a regular gym-goer and plays and watches all kinds of sport. Travel, the arts, and motoring are some of his other passions. 

On a personal level, there is still much he wants to achieve. “I want to continue to work hard, using my God-given talents to realise my full potential and to make a humble mark in society and in people’s lives.”

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept